ReviewFrontiers in surgery2022
Hysteroscopic metroplasty for the treatment of the dysmorphic uterus: A SWOT analysis.
Review in Frontiers in surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Adenomyosis and dysmorphic uterus: is there a correlation? Analysis of reproductive outcomes after hysteroscopic metroplasty.Facts, views & vision in ObGyn · 2025Article
- Prevalence of dysmorphic uterus in infertile women by 3D-TVUS: a retrospective longitudinal cohort study.Reproductive biology and endocrinology : RB&E · 2025Article
- Four-Dimensional Transvaginal Ultrasonography as a First-Line Non-Invasive Follow-Up After Hysteroscopic Metroplasty in Dysmorphic Uterus Cases.Journal of clinical medicine · 2025Article
- Reproductive Performance and Obstetric Outcomes after Hysteroscopic Metroplasty for T Shaped Uterus.Reproductive sciences (Thousand Oaks, Calif.) · 2025Article
- T-shaped dysmorphic uterus: discrepancies between current 3D-ultrasound diagnostic criteria.Archives of gynecology and obstetrics · 2025Article
- Hysteroscopy improves surgical outcomes of hydatidiform moles while reducing postoperative residuals.American journal of translational research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dysmorphic uterus or T-shaped uterus is an increasingly frequent diagnosis among the infertile population that has been associated to worse reproductive results. Hysteroscopic metroplasty is a safe and simple procedure that can improve the reproductive outcomes in this group of patients, although the benefits of this procedure remains controversial due to the lack of adequate scientific evidence. Objective: To analyze the hysteroscopic metroplasty using the SWOT (Strengths, Weaknesses, Opportunities and Threats) methodology. Data sources: An electronic search from inception each database up to December 2021 including the following databases was conducted: PubMed-MEDLINE, EMBASE, Web of Science, The Cochrane Library, and Google Scholar. Methods of study selection: Studies reporting outcomes of patients undergoing hysteroscopic metroplasty were included. Tabulation: Not applicable. Integration and Results: Clinical evidence from the included studies suggests an improvement in reproductive results after performing hysteroscopic metroplasty especially in women with recurrent pregnancy loss and previous infertility, but all of them have relevant methodological limitations. For this reason, benefits, risks and alternatives of this intervention should be considered with caution. Conclusions: Evidence from published data shows a probable association between dysmorphic uterus and poor reproductive outcomes. Hysteroscopic metroplasty in patients with dysmorphic uterus could improve pregnancy outcomes, but there is need of properly designed prospective controlled studies to determine the benefits of this technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.